BIO-RAD LABORATORIES, INC. 10-Q filing
Filed 2026-04-30 · Report date 2026-03-31 · 2026
Filing metadata
- Accession number
- 0000012208-26-000035
- Form type
- 10-Q
- CIK
- 0000012208
- Primary document
- https://www.sec.gov/Archives/edgar/data/12208/000001220826000035/bio-20260331.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for BIO-RAD LABORATORIES, INC..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $592.1M | - | - |
| Cost Of Revenue | $282.7M | - | - |
| Gross Profit | $309.4M | - | - |
| Operating Income | $34.1M | - | - |
| Net Income | $-527.1M | - | - |
| Eps Basic | -19.55 | - | - |
| Eps Diluted | -19.55 | - | - |
| Cash And Equivalents | $507.2M | - | - |
| Total Assets | $9.8B | - | - |
| Total Liabilities | $2.9B | - | - |
| Shareholders Equity | $6.9B | - | - |
| Operating Cash Flow | $108.1M | - | - |
| Capital Expenditures | $30.0M | - | - |